Literature DB >> 7713895

Molecular and biochemical evidence for the involvement of the Asp-333-His-523 pair in the catalytic mechanism of soluble epoxide hydrolase.

F Pinot1, D F Grant, J K Beetham, A G Parker, B Borhan, S Landt, A D Jones, B D Hammock.   

Abstract

In order to investigate the involvement of amino acids in the catalytic mechanism of the soluble epoxide hydrolase, different mutants of the murine enzyme were produced using the baculovirus expression system. Our results are consistent with the involvement of Asp-333 and His-523 in a catalytic mechanism similar to that of other alpha/beta hydrolase fold enzymes. Mutation of His-263 to asparagine led to the loss of approximately half the specific activity compared to wild-type enzyme. When His-332 was replaced by asparagine, 96.7% of the specific activity was lost and mutation of the conserved His-523 to glutamine led to a more dramatic loss of 99.9% of the specific activity. No activity was detectable after the replacement of Asp-333 by serine. However, more than 20% of the wild-type activity was retained in an Asp-333-->Asn mutant produced in Spodoptera frugiperda cells. We purified, by affinity chromatography, the wild-type and the Asp-333-->Asn mutant enzymes produced in Trichoplusia ni cells. We labeled these enzymes by incubating them with the epoxide containing radiolabeled substrate juvenile hormone III (JH III). The purified Asp-333-->Asn mutant bound 6% of the substrate compared to the wild-type soluble epoxide hydrolase. The mutant also showed 8% of the specific activity of the wild-type. Preincubation of the purified Asp-333-->Asn mutant at 37 degrees C (pH 8), however, led to a complete recovery of activity and to a change of isoelectric point (pI), both of which are consistent with hydrolysis of Asn-333 to aspartic acid. This intramolecular hydrolysis of asparagine to aspartic acid may explain the activity observed in this mutant. Wild-type enzyme that had been radiolabeled with the substrate was digested with trypsin. Using reverse phase-high pressure liquid chromatography, we isolated four radiolabeled peptides of similar polarity. These peptides were not radiolabeled if the enzyme was preincubated with a selective competitive inhibitor of soluble epoxide hydrolase 4-fluorochalcone oxide. This strongly suggested that these peptides contained a catalytic amino acid. Each peptide was characterized with N-terminal amino acid sequencing and electrospray mass spectrometry. All four radiolabeled peptides contained overlapping sequences. The only aspartic acid present in all four peptides and conserved in all epoxide hydrolases was Asp-333. These peptides resulted from cleavage at different trypsin sites and the mass of each was consistent with the covalent linkage of Asp-333 to the substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713895     DOI: 10.1074/jbc.270.14.7968

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

Authors:  M A Argiriadi; C Morisseau; B D Hammock; D W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.

Authors:  German A Gomez; Christophe Morisseau; Bruce D Hammock; David W Christianson
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

3.  Visualizing the Mechanism of Epoxide Hydrolysis by the Bacterial Virulence Enzyme Cif.

Authors:  Christopher D Bahl; Kelli L Hvorecny; Christophe Morisseau; Scott A Gerber; Dean R Madden
Journal:  Biochemistry       Date:  2016-01-22       Impact factor: 3.162

4.  Characterization of epoxide hydrolase activity in Alternaria alternata f. sp. lycopersici. Possible involvement in toxin production.

Authors:  F Pinot; E D Caldas; C Schmidt; D G Gilchrist; A D Jones; C K Winter; B D Hammock
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

5.  Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase.

Authors:  M Arand; H Hemmer; H Dürk; J Baratti; A Archelas; R Furstoss; F Oesch
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

6.  Catalysis of potato epoxide hydrolase, StEH1.

Authors:  Lisa T Elfström; Mikael Widersten
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

7.  Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation.

Authors:  Rebecca L Charles; Joseph R Burgoyne; Manuel Mayr; Steven M Weldon; Norbert Hubner; Hua Dong; Christophe Morisseau; Bruce D Hammock; Aimee Landar; Philip Eaton
Journal:  Circ Res       Date:  2010-12-16       Impact factor: 17.367

8.  Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation.

Authors:  Christophe Morisseau; Aaron T Wecksler; Catherine Deng; Hua Dong; Jun Yang; Kin Sing S Lee; Sean D Kodani; Bruce D Hammock
Journal:  J Lipid Res       Date:  2014-04-27       Impact factor: 5.922

9.  Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404 with Asp leads to a strongly increased turnover rate.

Authors:  M Arand; F Müller; A Mecky; W Hinz; P Urban; D Pompon; R Kellner; F Oesch
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

10.  Epoxide hydrolase: a mRNA induced by the fungal pathogen Alternaria alternata on rough lemon (Citrus jambhiri Lush).

Authors:  Kenji Gomi; Hiroyuki Yamamato; Kazuya Akimitsu
Journal:  Plant Mol Biol       Date:  2003-09       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.